Cyclodinone® (Cyclodynon®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substancePrutnyak ordinary fruit extractPrutnyak ordinary fruit extract
Similar drugsTo uncover
  • Cyclodinone®
    drops inwards 
    Bionoric CE     Germany
  • Cyclodinone®
    pills inwards 
    Bionoric CE     Germany
    • Dosage form: & nbspcoated tablets
    Composition:

    1 a tablet coated with a coating contains:

    of the active substance: common (Agnus castus) fruit extract dry 3,2-4,8 mg, corresponding to 40 mg of medicinal plant material;

    Excipients: povidone, silicon dioxide colloid, potato starch, lactose monohydrate, microcrystalline cellulose, magnesium stearate;

    shell composition: talc, titanium dioxide (IV) (E 171), iron oxide yellow (E 172), indigotine (E 132), macrogol 6000, emetacrylic and ethacrylic acid copolymer.

    Description:

    Round, biconvex, greenish-blue with a matte surface.

    Pharmacotherapeutic group:a plant remedy
    ATX: & nbsp

    G.02.C   Other drugs for the treatment of gynecological diseases

    Pharmacodynamics:

    The components of the drug have a normalizing effect on the concentration of sex hormones.

    The main active component of the drug is ordinary prutnyak. Dopaminergic effects of the drug, causing a decrease in prolactin production, eliminate hyperprolactinemia.Increased concentration of prolactin disrupts the secretion of gonadotropins, resulting in there is a violation of maturation follicles, ovulation and the formation of a yellow body, which further leads to an imbalance between estradiol and progesterone and can cause menstrual irregularities, as well as mastodynia.

    Unlike estrogens and other hormones, prolactin also has a direct stimulating effect on proliferative processes in the mammary glands, enhancing the formation of connective tissue and causing the expansion of the milk ducts. Reducing the prolactin content leads to the reverse development of pathological processes in the mammary glands and stops the pain syndrome.

    Rhythmic development and normalization of the ratio of gonadotropic hormones leads to the normalization of the second phase of the menstrual cycle.

    Indications:Violation of the menstrual cycle, premenstrual syndrome, mastodynia.
    Contraindications:Individual hypersensitivity to the components of the drug.
    Pregnancy and lactation:

    The drug should not be used during pregnancy, but also during breastfeeding.

    Dosing and Administration:

    The tablets covered with a cover, accept inside on 1 tablet 1 times a day, in the morning, not liquid, with a small amount of water.

    Treatment is carried out for 3 months, without interruption during menstruation. After the disappearance of symptoms and improvement of the condition should continue treatment for several weeks. If after the withdrawal of the drug complaints appear again, you need to consult a doctor.

    Side effects:

    Allergic skin reactions are rare.

    There are data on rare cases of transient psychomotor agitation, confusion and hallucinations.

    Overdose:

    Cases of overdose are unknown.

    Interaction:

    Patients taking antagonists of dopamine receptors may be mutually weakened by drugs.

    Interactions with other drugs have not been known to date.

    Special instructions:

    In case of occurrence at reception of a preparation of pains in mammary glands and-or delicacy, depression, and also in case of menstrual disturbances it is recommended to consult with the doctor.

    Tablets, coated with a shell, contain milk sugar (lactose).Lactose intolerance can be considered as a possible cause of epigastric pain and diarrhea.

    People with diabetes can take drops and tablets Cyclodinon ®, because a single dose of this drug contains less than 0.03 counted "bread units".

    Effect on the ability to drive transp. cf. and fur:

    The drug does not affect the ability to drive and control machinery.

    Form release / dosage:The tablets covered with a cover.
    Packaging:

    15 tablets in each blister.

    By 2 blisters (30 tablets) or 4 blisters (60 tablets) together with the instructions for use are placed in a cardboard box.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children!

    Shelf life:3 years.

    Do not use after the time specified on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:П N013429 / 01
    Date of registration:07.05.2010 / 20.07.2015
    The owner of the registration certificate:Bionoric CEBionoric CE Germany
    Manufacturer: & nbsp
    Representation: & nbspBIONORIKA LLC BIONORIKA LLC Russia
    Information update date: & nbsp10.09.2015
    Illustrated instructions
      Instructions
      Up